This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Synchrony (SYF) Up 4.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Synchrony (SYF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Truist (TFC) Faces Ratings Actions on TIH Divestiture Plan
by Zacks Equity Research
Rating agencies - Fitch Ratings and Moody's - take ratings actions on Truist (TFC) following the announcement of the company???s 80% stake sale in the TIH business.
SYF or BAM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SYF vs. BAM: Which Stock Is the Better Value Option?
Should Value Investors Buy Synchrony Financial (SYF) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include Royal Caribbean Cruises, General Motors, American Airlines, Synchrony Financial and Textron
by Zacks Equity Research
Royal Caribbean Cruises, General Motors, American Airlines, Synchrony Financial and Textron are part of the Zacks Screen of the Week article.
5 Lucrative PEG-Based Value Stocks for Investors
by Urmimala Biswas
Here are the five value stocks, RCL, GM, AAL, SYF and TXT, which fit our screening criteria.
Globe Life Inc. (GL) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Globe Life (GL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Globe Life (GL) Q4 Earnings Beat on Solid Investment Income
by Zacks Equity Research
Globe Life's (GL) Q4 results reflect a rise in insurance underwriting income, improved net investment income and premiums in the Life and Health segments, offset by higher expenses.
Despite Fast-paced Momentum, Synchrony (SYF) Is Still a Bargain Stock
by Zacks Equity Research
Synchrony (SYF) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Truist (TFC) to Streamline Business With Sterling Capital Sale
by Zacks Equity Research
Truist Financial (TFC) takes a major step in its ongoing efforts to realign and simplify operations by agreeing to divest its asset-management subsidiary, Sterling Capital, to Guardian Capital.
Aflac's (AFL) Q4 Earnings Miss on Higher Benefits and Claims
by Zacks Equity Research
Aflac (AFL) expects to exceed $1.8 billion in sales in the United States by 2025.
RenaissanceRe (RNR) Q4 Earnings Beat on Solid Investment Income
by Zacks Equity Research
RenaissanceRe's (RNR) fourth-quarter results reflect a solid underwriting performance and improved investment income. A rise in expenses partially offsets its quarterly results.
Synchrony (SYF) Expands CareCredit Network With PatientNow
by Zacks Equity Research
Synchrony (SYF) and PatientNow collaborate to offer CareCredit as a financing option at 4,800 aesthetic and cosmetic businesses in the country.
SYF vs. VIRT: Which Stock Is the Better Value Option?
by Zacks Equity Research
SYF vs. VIRT: Which Stock Is the Better Value Option?
Are Investors Undervaluing Synchrony Financial (SYF) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AmEx (AXP) Q4 Earnings Miss on High Client Engagement Costs
by Zacks Equity Research
American Express' (AXP) Q4 results reflect escalating expenses resulting from increased usage of travel-related benefits. Management expects EPS in the range of $12.65-$13.15 for 2024.
Synchrony (SYF) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Synchrony (SYF) Q4 Earnings Beat on Robust Receivables Growth
by Zacks Equity Research
Synchrony (SYF) expects net interest income in the range of $17.5-18.5 billion for 2024, higher than the previous year's figure of $17 billion.
Compared to Estimates, Synchrony (SYF) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Synchrony (SYF) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Synchrony (SYF) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Synchrony (SYF) delivered earnings and revenue surprises of 7.29% and 0.34%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Synchrony (SYF) to Buy Ally Financial's Point-of-Sale Business
by Zacks Equity Research
Synchrony's (SYF) pending acquisition of Ally's point-of-sale financing business is likely to help it expand in home improvement and healthcare financing.
Ally Financial (ALLY) to Sell POS Financing Business to Synchrony
by Zacks Equity Research
With an aim to focus on core business, Ally Financial (ALLY) announces a deal to divest, Ally Lending, its POS financing business to Synchrony (SYF).
Synchrony (SYF) Opts for Tech Investment to Ease Online Checkouts
by Zacks Equity Research
Synchrony (SYF) is testing the feasibility of a browser extension in a bid to make online checkouts safer and, subsequently, generate higher sales from its cardholders.